Abreu advises Grupo IMG on C2 Capital investment
Abreu Advogados has advised Grupo IMG on C2 Capital’s investment in Everbio, a subsidiary of Evertis Ibérica, through the issuance of convertible bonds worth €15 million. Everbio, established in 2024 by Grupo IMG, was created with the goal of unifying the R&D activities of the companies within the Grupo IMG, previously dispersed across Evertis, Selenis, and Renascis.
This investment is part of Grupo IMG’s investment plan of approximately €39.5 million. It will allow Everbio to establish, in Portalegre, an industrial innovation hub responsible for defining and implementing the Group’s R&D strategy, focusing on recycling and circularity, the development of high-performance sustainable materials, green and efficient production processes, and the promotion of collaborative innovation.
On Abreu’s side, the operation was led by hired partner Diogo Pessanha (pictured), with the participation of hired partner Miguel Rodrigues Leal, senior associate Benedita Pessanha, and trainee lawyers Inês Matos Soares and Pedro Ferreira G. Henriques.
